Learn about our comprehensive antibody validation methods to ensure monospecificity. Antibody Validation>>
Breast cancer is a multifaceted disease characterized by uncontrolled cell growth in the breast tissue. It encompasses several distinct types, differing in terms of origins and growth patterns. Techniques including Western blots, ELISA, flow cytometry, co-immunoprecipitation, and immunohistochemistry can distinguish among the different types of breast cancer and provide vital information about cell proliferation and disease progression, which is critical for the early detection, prognosis/monitoring, and treatment of the disease.
NeoBiotechnologies is your trusted partner in breast cancer research, offering a comprehensive range of high-quality IHC-validated antibodies targeting breast cancer protein biomarkers (see the table below).
Showing the single result
Showing the single result